Publication Date:
1990-06-08
Description:
Cytolytic T lymphocyte (CTL) responses were evaluated in humans immunized with recombinant human immunodeficiency virus type 1 (HIV) envelope glycoprotein gp160. Some vaccinees had gp160-specific CTLs that were shown by cloning to be CD4+. Although induced by exogenous antigen, most gp160-specific CTL clones also recognized gp160 synthesized endogenously in target cells. These clones lysed autologous CD4+ T lymphoblasts infected with HIV. Of particular interest were certain vaccine-induced clones that lysed HIV-infected cells, recognized gp160 from diverse HIV isolates, and did not participate in "innocent bystander" killing of noninfected CD4+ T cells that had bound gp120.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Orentas, R J -- Hildreth, J E -- Obah, E -- Polydefkis, M -- Smith, G E -- Clements, M L -- Siliciano, R F -- 5T32CA09243/CA/NCI NIH HHS/ -- AI28108/AI/NIAID NIH HHS/ -- N01AI62515/AI/NIAID NIH HHS/ -- etc. -- New York, N.Y. -- Science. 1990 Jun 8;248(4960):1234-7.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/2190315" target="_blank"〉PubMed〈/a〉
Keywords:
Cells, Cultured
;
Clone Cells
;
Cytotoxicity, Immunologic
;
Gene Products, env/*immunology
;
HIV/*immunology
;
HIV Envelope Protein gp160
;
HIV Seropositivity
;
Humans
;
Immunization
;
Macromolecular Substances
;
Protein Precursors/*immunology
;
Recombinant Proteins/immunology
;
T-Lymphocytes, Cytotoxic/*immunology
;
Viral Vaccines/*immunology
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink